nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—P-Glycoprotein Inhibitors—Ticagrelor—coronary artery disease	0.467	1	CiPCiCtD
Bosutinib—RPS6KB1—coronary artery disease	0.163	1	CbGaD
Bosutinib—ABCB1—Ticagrelor—coronary artery disease	0.0071	0.085	CbGbCtD
Bosutinib—ABCB1—Clopidogrel—coronary artery disease	0.00439	0.0525	CbGbCtD
Bosutinib—ABCB1—Perindopril—coronary artery disease	0.00439	0.0525	CbGbCtD
Bosutinib—CYP3A4—Ticagrelor—coronary artery disease	0.00425	0.0509	CbGbCtD
Bosutinib—ABCB1—Pitavastatin—coronary artery disease	0.00383	0.0459	CbGbCtD
Bosutinib—ABCB1—Telmisartan—coronary artery disease	0.00383	0.0459	CbGbCtD
Bosutinib—CYP3A4—Fenofibrate—coronary artery disease	0.00379	0.0454	CbGbCtD
Bosutinib—ABCB1—Enalapril—coronary artery disease	0.00364	0.0435	CbGbCtD
Bosutinib—ABCB1—Lisinopril—coronary artery disease	0.00364	0.0435	CbGbCtD
Bosutinib—ABCB1—Timolol—coronary artery disease	0.00309	0.037	CbGbCtD
Bosutinib—CYP3A4—Gemfibrozil—coronary artery disease	0.00303	0.0363	CbGbCtD
Bosutinib—ABCB1—Ezetimibe—coronary artery disease	0.00283	0.0338	CbGbCtD
Bosutinib—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00276	0.033	CbGbCtD
Bosutinib—ABCB1—Captopril—coronary artery disease	0.00272	0.0326	CbGbCtD
Bosutinib—CYP3A4—Clopidogrel—coronary artery disease	0.00263	0.0315	CbGbCtD
Bosutinib—ABCB1—Simvastatin—coronary artery disease	0.00263	0.0315	CbGbCtD
Bosutinib—ABCB1—Lovastatin—coronary artery disease	0.00257	0.0308	CbGbCtD
Bosutinib—ABCB1—Pravastatin—coronary artery disease	0.00257	0.0308	CbGbCtD
Bosutinib—CYP3A4—Eplerenone—coronary artery disease	0.00244	0.0293	CbGbCtD
Bosutinib—ABCB1—Atorvastatin—coronary artery disease	0.00234	0.028	CbGbCtD
Bosutinib—CYP3A4—Enalapril—coronary artery disease	0.00218	0.0261	CbGbCtD
Bosutinib—ABCB1—Losartan—coronary artery disease	0.00214	0.0257	CbGbCtD
Bosutinib—CYP3A4—Ezetimibe—coronary artery disease	0.00169	0.0203	CbGbCtD
Bosutinib—CYP3A4—Rosuvastatin—coronary artery disease	0.00169	0.0203	CbGbCtD
Bosutinib—CYP3A4—Simvastatin—coronary artery disease	0.00157	0.0189	CbGbCtD
Bosutinib—CYP3A4—Lovastatin—coronary artery disease	0.00154	0.0184	CbGbCtD
Bosutinib—CYP3A4—Pravastatin—coronary artery disease	0.00154	0.0184	CbGbCtD
Bosutinib—CYP3A4—Atorvastatin—coronary artery disease	0.0014	0.0168	CbGbCtD
Bosutinib—CYP3A4—Losartan—coronary artery disease	0.00128	0.0154	CbGbCtD
Bosutinib—Vandetanib—TEK—coronary artery disease	0.000746	0.433	CrCbGaD
Bosutinib—CASK—Pitavastatin—Rosuvastatin—coronary artery disease	0.000412	0.257	CbGdCrCtD
Bosutinib—Vandetanib—KDR—coronary artery disease	0.000364	0.211	CrCbGaD
Bosutinib—CASK—Pitavastatin—Atorvastatin—coronary artery disease	0.00035	0.218	CbGdCrCtD
Bosutinib—Vandetanib—VEGFA—coronary artery disease	0.000309	0.179	CrCbGaD
Bosutinib—MAP4K4—Testosterone Propionate—Eplerenone—coronary artery disease	0.00026	0.162	CbGdCrCtD
Bosutinib—CLK3—cardiac atrium—coronary artery disease	0.000251	0.0043	CbGeAlD
Bosutinib—CSNK1A1—myocardium—coronary artery disease	0.000251	0.00429	CbGeAlD
Bosutinib—HCK—myocardium—coronary artery disease	0.000249	0.00426	CbGeAlD
Bosutinib—CLK1—myocardium—coronary artery disease	0.000249	0.00426	CbGeAlD
Bosutinib—CSNK1E—cardiac ventricle—coronary artery disease	0.000247	0.00423	CbGeAlD
Bosutinib—SIK1—cardiac ventricle—coronary artery disease	0.000243	0.00416	CbGeAlD
Bosutinib—EIF2AK1—cardiac atrium—coronary artery disease	0.000243	0.00415	CbGeAlD
Bosutinib—STK25—heart—coronary artery disease	0.000242	0.00414	CbGeAlD
Bosutinib—EPHA3—heart—coronary artery disease	0.000241	0.00411	CbGeAlD
Bosutinib—DMPK—cardiovascular system—coronary artery disease	0.000239	0.0041	CbGeAlD
Bosutinib—WEE1—cardiovascular system—coronary artery disease	0.000239	0.0041	CbGeAlD
Bosutinib—ULK3—cardiac ventricle—coronary artery disease	0.000238	0.00407	CbGeAlD
Bosutinib—MAP2K2—cardiac ventricle—coronary artery disease	0.000238	0.00407	CbGeAlD
Bosutinib—TLK1—blood—coronary artery disease	0.000237	0.00405	CbGeAlD
Bosutinib—PLK2—heart—coronary artery disease	0.000236	0.00403	CbGeAlD
Bosutinib—VRK2—cardiac atrium—coronary artery disease	0.000235	0.00403	CbGeAlD
Bosutinib—SIK3—heart—coronary artery disease	0.000234	0.004	CbGeAlD
Bosutinib—MAP3K7—cardiac ventricle—coronary artery disease	0.000234	0.004	CbGeAlD
Bosutinib—PRKCQ—blood—coronary artery disease	0.000234	0.00399	CbGeAlD
Bosutinib—TBK1—cardiac ventricle—coronary artery disease	0.000231	0.00395	CbGeAlD
Bosutinib—SIK1—myocardium—coronary artery disease	0.000229	0.00391	CbGeAlD
Bosutinib—IRAK1—cardiac ventricle—coronary artery disease	0.000227	0.00388	CbGeAlD
Bosutinib—EPHA4—myocardium—coronary artery disease	0.000226	0.00387	CbGeAlD
Bosutinib—STK4—heart—coronary artery disease	0.000225	0.00385	CbGeAlD
Bosutinib—PKMYT1—blood—coronary artery disease	0.000225	0.00384	CbGeAlD
Bosutinib—MAP2K2—myocardium—coronary artery disease	0.000224	0.00383	CbGeAlD
Bosutinib—ULK3—myocardium—coronary artery disease	0.000224	0.00383	CbGeAlD
Bosutinib—CAMK1D—heart—coronary artery disease	0.000223	0.00381	CbGeAlD
Bosutinib—RPS6KB1—cardiac ventricle—coronary artery disease	0.000222	0.0038	CbGeAlD
Bosutinib—PLK2—cardiovascular system—coronary artery disease	0.000222	0.0038	CbGeAlD
Bosutinib—AXL—cardiac ventricle—coronary artery disease	0.00022	0.00377	CbGeAlD
Bosutinib—STK24—heart—coronary artery disease	0.00022	0.00376	CbGeAlD
Bosutinib—MAP3K7—myocardium—coronary artery disease	0.00022	0.00376	CbGeAlD
Bosutinib—BMX—blood—coronary artery disease	0.000219	0.00375	CbGeAlD
Bosutinib—CLK3—blood—coronary artery disease	0.000219	0.00375	CbGeAlD
Bosutinib—PTK2—myocardium—coronary artery disease	0.000217	0.00372	CbGeAlD
Bosutinib—TBK1—myocardium—coronary artery disease	0.000217	0.00372	CbGeAlD
Bosutinib—WEE1—cardiac atrium—coronary artery disease	0.000217	0.00371	CbGeAlD
Bosutinib—DMPK—cardiac atrium—coronary artery disease	0.000217	0.00371	CbGeAlD
Bosutinib—BLK—blood—coronary artery disease	0.000217	0.00371	CbGeAlD
Bosutinib—IRAK1—myocardium—coronary artery disease	0.000213	0.00365	CbGeAlD
Bosutinib—FER—heart—coronary artery disease	0.000213	0.00364	CbGeAlD
Bosutinib—SLK—cardiac ventricle—coronary artery disease	0.000212	0.00363	CbGeAlD
Bosutinib—EIF2AK1—blood—coronary artery disease	0.000212	0.00362	CbGeAlD
Bosutinib—EPHB4—cardiac ventricle—coronary artery disease	0.00021	0.0036	CbGeAlD
Bosutinib—RPS6KB1—myocardium—coronary artery disease	0.000209	0.00358	CbGeAlD
Bosutinib—MAP4K1—heart—coronary artery disease	0.000209	0.00357	CbGeAlD
Bosutinib—TXK—blood—coronary artery disease	0.000207	0.00355	CbGeAlD
Bosutinib—STK25—cardiac atrium—coronary artery disease	0.000207	0.00354	CbGeAlD
Bosutinib—AXL—myocardium—coronary artery disease	0.000207	0.00354	CbGeAlD
Bosutinib—FYN—cardiac ventricle—coronary artery disease	0.000206	0.00352	CbGeAlD
Bosutinib—FES—blood—coronary artery disease	0.000205	0.00351	CbGeAlD
Bosutinib—VRK2—blood—coronary artery disease	0.000205	0.00351	CbGeAlD
Bosutinib—TNK2—heart—coronary artery disease	0.000205	0.0035	CbGeAlD
Bosutinib—MAP4K2—heart—coronary artery disease	0.000202	0.00345	CbGeAlD
Bosutinib—PLK2—cardiac atrium—coronary artery disease	0.000201	0.00345	CbGeAlD
Bosutinib—TNIK—blood—coronary artery disease	0.000201	0.00344	CbGeAlD
Bosutinib—SYK—blood—coronary artery disease	0.000201	0.00344	CbGeAlD
Bosutinib—MAP3K3—cardiac ventricle—coronary artery disease	0.000201	0.00344	CbGeAlD
Bosutinib—SIK3—cardiac atrium—coronary artery disease	0.0002	0.00342	CbGeAlD
Bosutinib—CDK2—blood—coronary artery disease	0.000199	0.00341	CbGeAlD
Bosutinib—SLK—myocardium—coronary artery disease	0.000199	0.00341	CbGeAlD
Bosutinib—STK3—heart—coronary artery disease	0.000199	0.0034	CbGeAlD
Bosutinib—ERBB4—heart—coronary artery disease	0.000199	0.0034	CbGeAlD
Bosutinib—EPHB4—myocardium—coronary artery disease	0.000198	0.00339	CbGeAlD
Bosutinib—STK26—blood—coronary artery disease	0.000198	0.00338	CbGeAlD
Bosutinib—ROCK1—heart—coronary artery disease	0.000196	0.00336	CbGeAlD
Bosutinib—FYN—myocardium—coronary artery disease	0.000194	0.00332	CbGeAlD
Bosutinib—CHEK2—blood—coronary artery disease	0.000191	0.00327	CbGeAlD
Bosutinib—BMPR2—heart—coronary artery disease	0.000191	0.00326	CbGeAlD
Bosutinib—CAMK1D—cardiac atrium—coronary artery disease	0.00019	0.00326	CbGeAlD
Bosutinib—MAP3K3—myocardium—coronary artery disease	0.000189	0.00324	CbGeAlD
Bosutinib—WEE1—blood—coronary artery disease	0.000189	0.00324	CbGeAlD
Bosutinib—DMPK—blood—coronary artery disease	0.000189	0.00324	CbGeAlD
Bosutinib—EPHB3—heart—coronary artery disease	0.000189	0.00324	CbGeAlD
Bosutinib—STK36—heart—coronary artery disease	0.000189	0.00324	CbGeAlD
Bosutinib—ERBB4—cardiovascular system—coronary artery disease	0.000188	0.00321	CbGeAlD
Bosutinib—MERTK—heart—coronary artery disease	0.000187	0.0032	CbGeAlD
Bosutinib—YES1—cardiac ventricle—coronary artery disease	0.000186	0.00318	CbGeAlD
Bosutinib—ROCK1—cardiovascular system—coronary artery disease	0.000185	0.00317	CbGeAlD
Bosutinib—MAP4K4—heart—coronary artery disease	0.000184	0.00314	CbGeAlD
Bosutinib—TAOK3—cardiac ventricle—coronary artery disease	0.000184	0.00314	CbGeAlD
Bosutinib—BCR—heart—coronary artery disease	0.000182	0.00312	CbGeAlD
Bosutinib—FER—cardiac atrium—coronary artery disease	0.000182	0.00311	CbGeAlD
Bosutinib—MAP3K12—heart—coronary artery disease	0.000181	0.0031	CbGeAlD
Bosutinib—STK25—blood—coronary artery disease	0.000181	0.00309	CbGeAlD
Bosutinib—BMPR2—cardiovascular system—coronary artery disease	0.00018	0.00308	CbGeAlD
Bosutinib—CHEK2—Pitavastatin—Rosuvastatin—coronary artery disease	0.000179	0.112	CbGdCrCtD
Bosutinib—ERBB3—Alprenolol—Penbutolol—coronary artery disease	0.000178	0.111	CbGdCrCtD
Bosutinib—MAP2K1—heart—coronary artery disease	0.000177	0.00303	CbGeAlD
Bosutinib—STK35—heart—coronary artery disease	0.000177	0.00303	CbGeAlD
Bosutinib—CSK—heart—coronary artery disease	0.000176	0.00301	CbGeAlD
Bosutinib—PLK2—blood—coronary artery disease	0.000176	0.00301	CbGeAlD
Bosutinib—CSNK1A1—heart—coronary artery disease	0.000175	0.00299	CbGeAlD
Bosutinib—YES1—myocardium—coronary artery disease	0.000175	0.00299	CbGeAlD
Bosutinib—CLK1—heart—coronary artery disease	0.000174	0.00297	CbGeAlD
Bosutinib—HCK—heart—coronary artery disease	0.000174	0.00297	CbGeAlD
Bosutinib—MAP4K4—cardiovascular system—coronary artery disease	0.000173	0.00296	CbGeAlD
Bosutinib—ABL2—heart—coronary artery disease	0.000173	0.00296	CbGeAlD
Bosutinib—TAOK3—myocardium—coronary artery disease	0.000173	0.00295	CbGeAlD
Bosutinib—BMP2K—heart—coronary artery disease	0.000171	0.00292	CbGeAlD
Bosutinib—CAMK2G—heart—coronary artery disease	0.000171	0.00292	CbGeAlD
Bosutinib—ERBB4—cardiac atrium—coronary artery disease	0.00017	0.00291	CbGeAlD
Bosutinib—LRRK2—heart—coronary artery disease	0.000169	0.00289	CbGeAlD
Bosutinib—EGFR—heart—coronary artery disease	0.000169	0.00289	CbGeAlD
Bosutinib—STK4—blood—coronary artery disease	0.000168	0.00287	CbGeAlD
Bosutinib—MAP2K1—cardiovascular system—coronary artery disease	0.000167	0.00286	CbGeAlD
Bosutinib—CSK—cardiovascular system—coronary artery disease	0.000166	0.00284	CbGeAlD
Bosutinib—CAMK1D—blood—coronary artery disease	0.000166	0.00284	CbGeAlD
Bosutinib—CSNK1A1—cardiovascular system—coronary artery disease	0.000165	0.00282	CbGeAlD
Bosutinib—PTK2B—heart—coronary artery disease	0.000165	0.00282	CbGeAlD
Bosutinib—STK24—blood—coronary artery disease	0.000164	0.00281	CbGeAlD
Bosutinib—CLK1—cardiovascular system—coronary artery disease	0.000164	0.00281	CbGeAlD
Bosutinib—BMPR2—cardiac atrium—coronary artery disease	0.000163	0.00279	CbGeAlD
Bosutinib—CSNK1E—heart—coronary artery disease	0.000162	0.00277	CbGeAlD
Bosutinib—CAMK2G—cardiovascular system—coronary artery disease	0.000161	0.00276	CbGeAlD
Bosutinib—SIK1—heart—coronary artery disease	0.00016	0.00273	CbGeAlD
Bosutinib—IRAK4—heart—coronary artery disease	0.00016	0.00273	CbGeAlD
Bosutinib—FER—blood—coronary artery disease	0.000159	0.00272	CbGeAlD
Bosutinib—ALK—blood—coronary artery disease	0.000159	0.00272	CbGeAlD
Bosutinib—EPHA4—heart—coronary artery disease	0.000158	0.0027	CbGeAlD
Bosutinib—LYN—blood—coronary artery disease	0.000158	0.0027	CbGeAlD
Bosutinib—MAP4K4—cardiac atrium—coronary artery disease	0.000157	0.00269	CbGeAlD
Bosutinib—ERBB3—heart—coronary artery disease	0.000156	0.00268	CbGeAlD
Bosutinib—MAP2K2—heart—coronary artery disease	0.000156	0.00267	CbGeAlD
Bosutinib—ULK3—heart—coronary artery disease	0.000156	0.00267	CbGeAlD
Bosutinib—BCR—cardiac atrium—coronary artery disease	0.000156	0.00267	CbGeAlD
Bosutinib—MAP4K1—blood—coronary artery disease	0.000156	0.00266	CbGeAlD
Bosutinib—PTK2B—cardiovascular system—coronary artery disease	0.000156	0.00266	CbGeAlD
Bosutinib—MAP3K2—heart—coronary artery disease	0.000155	0.00265	CbGeAlD
Bosutinib—BTK—blood—coronary artery disease	0.000155	0.00265	CbGeAlD
Bosutinib—MAP2K5—myocardium—coronary artery disease	0.000155	0.00265	CbGeAlD
Bosutinib—MAP3K12—cardiac atrium—coronary artery disease	0.000155	0.00265	CbGeAlD
Bosutinib—MAP3K7—heart—coronary artery disease	0.000154	0.00263	CbGeAlD
Bosutinib—CHEK2—Pitavastatin—Atorvastatin—coronary artery disease	0.000152	0.095	CbGdCrCtD
Bosutinib—TBK1—heart—coronary artery disease	0.000152	0.0026	CbGeAlD
Bosutinib—PTK2—heart—coronary artery disease	0.000152	0.0026	CbGeAlD
Bosutinib—STK35—cardiac atrium—coronary artery disease	0.000152	0.00259	CbGeAlD
Bosutinib—CSK—cardiac atrium—coronary artery disease	0.000151	0.00258	CbGeAlD
Bosutinib—MAP4K2—blood—coronary artery disease	0.00015	0.00257	CbGeAlD
Bosutinib—CSNK1A1—cardiac atrium—coronary artery disease	0.00015	0.00256	CbGeAlD
Bosutinib—IRAK1—heart—coronary artery disease	0.000149	0.00255	CbGeAlD
Bosutinib—CLK1—cardiac atrium—coronary artery disease	0.000149	0.00254	CbGeAlD
Bosutinib—STK3—blood—coronary artery disease	0.000148	0.00254	CbGeAlD
Bosutinib—MAP2K2—cardiovascular system—coronary artery disease	0.000147	0.00252	CbGeAlD
Bosutinib—ROCK1—blood—coronary artery disease	0.000147	0.00251	CbGeAlD
Bosutinib—RPS6KB1—heart—coronary artery disease	0.000146	0.0025	CbGeAlD
Bosutinib—LCK—heart—coronary artery disease	0.000145	0.00248	CbGeAlD
Bosutinib—FGR—heart—coronary artery disease	0.000145	0.00248	CbGeAlD
Bosutinib—AXL—heart—coronary artery disease	0.000145	0.00247	CbGeAlD
Bosutinib—PTK2—cardiovascular system—coronary artery disease	0.000143	0.00245	CbGeAlD
Bosutinib—TBK1—cardiovascular system—coronary artery disease	0.000143	0.00245	CbGeAlD
Bosutinib—PDGFRB—cardiac ventricle—coronary artery disease	0.000142	0.00244	CbGeAlD
Bosutinib—Gefitinib—CYP2C19—coronary artery disease	0.000142	0.0825	CrCbGaD
Bosutinib—STK36—blood—coronary artery disease	0.000141	0.00242	CbGeAlD
Bosutinib—MERTK—blood—coronary artery disease	0.00014	0.00239	CbGeAlD
Bosutinib—SLK—heart—coronary artery disease	0.000139	0.00238	CbGeAlD
Bosutinib—EPHB4—heart—coronary artery disease	0.000138	0.00236	CbGeAlD
Bosutinib—RPS6KB1—cardiovascular system—coronary artery disease	0.000138	0.00236	CbGeAlD
Bosutinib—MAP4K4—blood—coronary artery disease	0.000137	0.00234	CbGeAlD
Bosutinib—FGR—cardiovascular system—coronary artery disease	0.000137	0.00234	CbGeAlD
Bosutinib—SIK1—cardiac atrium—coronary artery disease	0.000137	0.00234	CbGeAlD
Bosutinib—AXL—cardiovascular system—coronary artery disease	0.000136	0.00233	CbGeAlD
Bosutinib—NUAK2—blood—coronary artery disease	0.000136	0.00233	CbGeAlD
Bosutinib—BCR—blood—coronary artery disease	0.000136	0.00233	CbGeAlD
Bosutinib—EPHA2—heart—coronary artery disease	0.000136	0.00232	CbGeAlD
Bosutinib—FYN—heart—coronary artery disease	0.000135	0.00231	CbGeAlD
Bosutinib—EPHA4—cardiac atrium—coronary artery disease	0.000135	0.00231	CbGeAlD
Bosutinib—MAP3K12—blood—coronary artery disease	0.000135	0.00231	CbGeAlD
Bosutinib—PDGFRB—myocardium—coronary artery disease	0.000134	0.00229	CbGeAlD
Bosutinib—MAP2K2—cardiac atrium—coronary artery disease	0.000134	0.00228	CbGeAlD
Bosutinib—ULK3—cardiac atrium—coronary artery disease	0.000134	0.00228	CbGeAlD
Bosutinib—MAP2K1—blood—coronary artery disease	0.000132	0.00226	CbGeAlD
Bosutinib—MAP3K3—heart—coronary artery disease	0.000132	0.00226	CbGeAlD
Bosutinib—MAP4K5—heart—coronary artery disease	0.000132	0.00226	CbGeAlD
Bosutinib—CSK—blood—coronary artery disease	0.000131	0.00225	CbGeAlD
Bosutinib—MAP3K7—cardiac atrium—coronary artery disease	0.000131	0.00225	CbGeAlD
Bosutinib—CSNK1A1—blood—coronary artery disease	0.000131	0.00223	CbGeAlD
Bosutinib—EPHB4—cardiovascular system—coronary artery disease	0.00013	0.00223	CbGeAlD
Bosutinib—TBK1—cardiac atrium—coronary artery disease	0.00013	0.00222	CbGeAlD
Bosutinib—HCK—blood—coronary artery disease	0.00013	0.00222	CbGeAlD
Bosutinib—CLK1—blood—coronary artery disease	0.00013	0.00222	CbGeAlD
Bosutinib—ABL2—blood—coronary artery disease	0.000129	0.00221	CbGeAlD
Bosutinib—EPHA2—cardiovascular system—coronary artery disease	0.000128	0.00219	CbGeAlD
Bosutinib—FYN—cardiovascular system—coronary artery disease	0.000128	0.00218	CbGeAlD
Bosutinib—CAMK2G—blood—coronary artery disease	0.000127	0.00218	CbGeAlD
Bosutinib—BMP2K—blood—coronary artery disease	0.000127	0.00218	CbGeAlD
Bosutinib—ABL1—cardiac ventricle—coronary artery disease	0.000127	0.00217	CbGeAlD
Bosutinib—LRRK2—blood—coronary artery disease	0.000126	0.00216	CbGeAlD
Bosutinib—RPS6KB1—cardiac atrium—coronary artery disease	0.000125	0.00214	CbGeAlD
Bosutinib—MAP3K3—cardiovascular system—coronary artery disease	0.000125	0.00213	CbGeAlD
Bosutinib—AXL—cardiac atrium—coronary artery disease	0.000124	0.00211	CbGeAlD
Bosutinib—PTK2B—blood—coronary artery disease	0.000123	0.0021	CbGeAlD
Bosutinib—YES1—heart—coronary artery disease	0.000122	0.00209	CbGeAlD
Bosutinib—CSNK1E—blood—coronary artery disease	0.000121	0.00207	CbGeAlD
Bosutinib—STK10—heart—coronary artery disease	0.000121	0.00207	CbGeAlD
Bosutinib—TAOK3—heart—coronary artery disease	0.000121	0.00206	CbGeAlD
Bosutinib—ABL1—myocardium—coronary artery disease	0.000119	0.00204	CbGeAlD
Bosutinib—SIK1—blood—coronary artery disease	0.000119	0.00204	CbGeAlD
Bosutinib—IRAK4—blood—coronary artery disease	0.000119	0.00204	CbGeAlD
Bosutinib—SLK—cardiac atrium—coronary artery disease	0.000119	0.00204	CbGeAlD
Bosutinib—EPHB4—cardiac atrium—coronary artery disease	0.000118	0.00202	CbGeAlD
Bosutinib—EPHA4—blood—coronary artery disease	0.000118	0.00202	CbGeAlD
Bosutinib—SRC—heart—coronary artery disease	0.000117	0.00201	CbGeAlD
Bosutinib—MAP2K2—blood—coronary artery disease	0.000116	0.00199	CbGeAlD
Bosutinib—ULK3—blood—coronary artery disease	0.000116	0.00199	CbGeAlD
Bosutinib—EPHA2—cardiac atrium—coronary artery disease	0.000116	0.00198	CbGeAlD
Bosutinib—FYN—cardiac atrium—coronary artery disease	0.000116	0.00198	CbGeAlD
Bosutinib—MAP3K2—blood—coronary artery disease	0.000116	0.00198	CbGeAlD
Bosutinib—MAP3K7—blood—coronary artery disease	0.000115	0.00196	CbGeAlD
Bosutinib—STK10—cardiovascular system—coronary artery disease	0.000114	0.00195	CbGeAlD
Bosutinib—TAOK3—cardiovascular system—coronary artery disease	0.000114	0.00195	CbGeAlD
Bosutinib—PTK2—blood—coronary artery disease	0.000113	0.00194	CbGeAlD
Bosutinib—TBK1—blood—coronary artery disease	0.000113	0.00194	CbGeAlD
Bosutinib—MAP4K5—cardiac atrium—coronary artery disease	0.000113	0.00193	CbGeAlD
Bosutinib—MAP3K3—cardiac atrium—coronary artery disease	0.000113	0.00193	CbGeAlD
Bosutinib—IRAK1—blood—coronary artery disease	0.000111	0.0019	CbGeAlD
Bosutinib—SRC—cardiovascular system—coronary artery disease	0.000111	0.0019	CbGeAlD
Bosutinib—RPS6KB1—blood—coronary artery disease	0.000109	0.00186	CbGeAlD
Bosutinib—LCK—blood—coronary artery disease	0.000108	0.00185	CbGeAlD
Bosutinib—FGR—blood—coronary artery disease	0.000108	0.00185	CbGeAlD
Bosutinib—MAP2K5—heart—coronary artery disease	0.000108	0.00185	CbGeAlD
Bosutinib—CSF1R—heart—coronary artery disease	0.000105	0.0018	CbGeAlD
Bosutinib—YES1—cardiac atrium—coronary artery disease	0.000104	0.00179	CbGeAlD
Bosutinib—SLK—blood—coronary artery disease	0.000104	0.00178	CbGeAlD
Bosutinib—TAOK3—cardiac atrium—coronary artery disease	0.000103	0.00176	CbGeAlD
Bosutinib—EPHB4—blood—coronary artery disease	0.000103	0.00176	CbGeAlD
Bosutinib—MAP2K5—cardiovascular system—coronary artery disease	0.000102	0.00174	CbGeAlD
Bosutinib—EPHA2—blood—coronary artery disease	0.000101	0.00173	CbGeAlD
Bosutinib—FYN—blood—coronary artery disease	0.000101	0.00173	CbGeAlD
Bosutinib—SRC—cardiac atrium—coronary artery disease	0.0001	0.00172	CbGeAlD
Bosutinib—CSF1R—cardiovascular system—coronary artery disease	9.95e-05	0.0017	CbGeAlD
Bosutinib—MAP4K5—blood—coronary artery disease	9.87e-05	0.00169	CbGeAlD
Bosutinib—MAP3K3—blood—coronary artery disease	9.87e-05	0.00169	CbGeAlD
Bosutinib—PDGFRB—heart—coronary artery disease	9.35e-05	0.0016	CbGeAlD
Bosutinib—MAP2K5—cardiac atrium—coronary artery disease	9.24e-05	0.00158	CbGeAlD
Bosutinib—YES1—blood—coronary artery disease	9.11e-05	0.00156	CbGeAlD
Bosutinib—STK10—blood—coronary artery disease	9.03e-05	0.00154	CbGeAlD
Bosutinib—CSF1R—cardiac atrium—coronary artery disease	9.02e-05	0.00154	CbGeAlD
Bosutinib—TAOK3—blood—coronary artery disease	8.99e-05	0.00154	CbGeAlD
Bosutinib—PDGFRB—cardiovascular system—coronary artery disease	8.82e-05	0.00151	CbGeAlD
Bosutinib—SRC—blood—coronary artery disease	8.76e-05	0.0015	CbGeAlD
Bosutinib—ABL1—heart—coronary artery disease	8.34e-05	0.00143	CbGeAlD
Bosutinib—Vandetanib—ALB—coronary artery disease	8.3e-05	0.0482	CrCbGaD
Bosutinib—MAP2K5—blood—coronary artery disease	8.06e-05	0.00138	CbGeAlD
Bosutinib—PDGFRB—cardiac atrium—coronary artery disease	8e-05	0.00137	CbGeAlD
Bosutinib—Gefitinib—ALB—coronary artery disease	7.89e-05	0.0458	CrCbGaD
Bosutinib—CSF1R—blood—coronary artery disease	7.87e-05	0.00135	CbGeAlD
Bosutinib—ABL1—cardiovascular system—coronary artery disease	7.87e-05	0.00135	CbGeAlD
Bosutinib—CHEK2—Testosterone Propionate—Eplerenone—coronary artery disease	7.28e-05	0.0454	CbGdCrCtD
Bosutinib—ABL1—cardiac atrium—coronary artery disease	7.13e-05	0.00122	CbGeAlD
Bosutinib—PDGFRB—blood—coronary artery disease	6.98e-05	0.00119	CbGeAlD
Bosutinib—ABL1—blood—coronary artery disease	6.22e-05	0.00106	CbGeAlD
Bosutinib—Urticaria—Telmisartan—coronary artery disease	4.36e-05	0.000464	CcSEcCtD
Bosutinib—Cough—Timolol—coronary artery disease	4.35e-05	0.000463	CcSEcCtD
Bosutinib—Vomiting—Clopidogrel—coronary artery disease	4.35e-05	0.000463	CcSEcCtD
Bosutinib—Diarrhoea—Simvastatin—coronary artery disease	4.35e-05	0.000463	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Furosemide—coronary artery disease	4.35e-05	0.000462	CcSEcCtD
Bosutinib—Myalgia—Ramipril—coronary artery disease	4.35e-05	0.000462	CcSEcCtD
Bosutinib—Arthralgia—Ramipril—coronary artery disease	4.35e-05	0.000462	CcSEcCtD
Bosutinib—Chest pain—Ramipril—coronary artery disease	4.35e-05	0.000462	CcSEcCtD
Bosutinib—Fatigue—Furosemide—coronary artery disease	4.34e-05	0.000462	CcSEcCtD
Bosutinib—Abdominal pain—Telmisartan—coronary artery disease	4.34e-05	0.000461	CcSEcCtD
Bosutinib—Body temperature increased—Telmisartan—coronary artery disease	4.34e-05	0.000461	CcSEcCtD
Bosutinib—Dyspnoea—Losartan—coronary artery disease	4.33e-05	0.000461	CcSEcCtD
Bosutinib—Vomiting—Lovastatin—coronary artery disease	4.32e-05	0.00046	CcSEcCtD
Bosutinib—Dizziness—Eplerenone—coronary artery disease	4.32e-05	0.000459	CcSEcCtD
Bosutinib—Rash—Clopidogrel—coronary artery disease	4.32e-05	0.000459	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	4.32e-05	0.000459	CcSEcCtD
Bosutinib—Dermatitis—Clopidogrel—coronary artery disease	4.31e-05	0.000459	CcSEcCtD
Bosutinib—Asthenia—Valsartan—coronary artery disease	4.31e-05	0.000458	CcSEcCtD
Bosutinib—Pain—Furosemide—coronary artery disease	4.31e-05	0.000458	CcSEcCtD
Bosutinib—Ill-defined disorder—Lisinopril—coronary artery disease	4.29e-05	0.000457	CcSEcCtD
Bosutinib—Discomfort—Ramipril—coronary artery disease	4.29e-05	0.000457	CcSEcCtD
Bosutinib—Asthenia—Olmesartan—coronary artery disease	4.29e-05	0.000456	CcSEcCtD
Bosutinib—Headache—Clopidogrel—coronary artery disease	4.29e-05	0.000456	CcSEcCtD
Bosutinib—Rash—Lovastatin—coronary artery disease	4.29e-05	0.000456	CcSEcCtD
Bosutinib—Dermatitis—Lovastatin—coronary artery disease	4.28e-05	0.000456	CcSEcCtD
Bosutinib—Anaemia—Lisinopril—coronary artery disease	4.28e-05	0.000455	CcSEcCtD
Bosutinib—Feeling abnormal—Perindopril—coronary artery disease	4.27e-05	0.000454	CcSEcCtD
Bosutinib—Headache—Lovastatin—coronary artery disease	4.26e-05	0.000453	CcSEcCtD
Bosutinib—Pruritus—Valsartan—coronary artery disease	4.25e-05	0.000452	CcSEcCtD
Bosutinib—Chest pain—Timolol—coronary artery disease	4.25e-05	0.000452	CcSEcCtD
Bosutinib—Myalgia—Timolol—coronary artery disease	4.25e-05	0.000452	CcSEcCtD
Bosutinib—Arthralgia—Timolol—coronary artery disease	4.25e-05	0.000452	CcSEcCtD
Bosutinib—Vomiting—Ezetimibe—coronary artery disease	4.24e-05	0.000451	CcSEcCtD
Bosutinib—Gastrointestinal pain—Perindopril—coronary artery disease	4.24e-05	0.000451	CcSEcCtD
Bosutinib—Pruritus—Olmesartan—coronary artery disease	4.23e-05	0.00045	CcSEcCtD
Bosutinib—Decreased appetite—Losartan—coronary artery disease	4.22e-05	0.000449	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	4.22e-05	0.000449	CcSEcCtD
Bosutinib—Body temperature increased—Captopril—coronary artery disease	4.22e-05	0.000449	CcSEcCtD
Bosutinib—Abdominal pain—Captopril—coronary artery disease	4.22e-05	0.000449	CcSEcCtD
Bosutinib—Dizziness—Simvastatin—coronary artery disease	4.21e-05	0.000447	CcSEcCtD
Bosutinib—Rash—Ezetimibe—coronary artery disease	4.21e-05	0.000447	CcSEcCtD
Bosutinib—Dermatitis—Ezetimibe—coronary artery disease	4.2e-05	0.000447	CcSEcCtD
Bosutinib—Discomfort—Timolol—coronary artery disease	4.2e-05	0.000446	CcSEcCtD
Bosutinib—Asthenia—Niacin—coronary artery disease	4.19e-05	0.000446	CcSEcCtD
Bosutinib—Fatigue—Losartan—coronary artery disease	4.19e-05	0.000446	CcSEcCtD
Bosutinib—Headache—Ezetimibe—coronary artery disease	4.18e-05	0.000444	CcSEcCtD
Bosutinib—Malaise—Lisinopril—coronary artery disease	4.17e-05	0.000444	CcSEcCtD
Bosutinib—Oedema—Ramipril—coronary artery disease	4.17e-05	0.000443	CcSEcCtD
Bosutinib—Anaphylactic shock—Ramipril—coronary artery disease	4.17e-05	0.000443	CcSEcCtD
Bosutinib—Pain—Losartan—coronary artery disease	4.15e-05	0.000442	CcSEcCtD
Bosutinib—Vomiting—Eplerenone—coronary artery disease	4.15e-05	0.000442	CcSEcCtD
Bosutinib—Feeling abnormal—Furosemide—coronary artery disease	4.15e-05	0.000441	CcSEcCtD
Bosutinib—Leukopenia—Lisinopril—coronary artery disease	4.14e-05	0.000441	CcSEcCtD
Bosutinib—Nausea—Fenofibrate—coronary artery disease	4.14e-05	0.00044	CcSEcCtD
Bosutinib—Pruritus—Niacin—coronary artery disease	4.13e-05	0.00044	CcSEcCtD
Bosutinib—Asthenia—Pravastatin—coronary artery disease	4.13e-05	0.000439	CcSEcCtD
Bosutinib—Gastrointestinal pain—Furosemide—coronary artery disease	4.12e-05	0.000438	CcSEcCtD
Bosutinib—Rash—Eplerenone—coronary artery disease	4.12e-05	0.000438	CcSEcCtD
Bosutinib—Urticaria—Perindopril—coronary artery disease	4.11e-05	0.000438	CcSEcCtD
Bosutinib—Dermatitis—Eplerenone—coronary artery disease	4.11e-05	0.000437	CcSEcCtD
Bosutinib—Diarrhoea—Valsartan—coronary artery disease	4.11e-05	0.000437	CcSEcCtD
Bosutinib—Abdominal pain—Perindopril—coronary artery disease	4.09e-05	0.000436	CcSEcCtD
Bosutinib—Body temperature increased—Perindopril—coronary artery disease	4.09e-05	0.000436	CcSEcCtD
Bosutinib—Diarrhoea—Olmesartan—coronary artery disease	4.09e-05	0.000435	CcSEcCtD
Bosutinib—Headache—Eplerenone—coronary artery disease	4.09e-05	0.000435	CcSEcCtD
Bosutinib—Nervous system disorder—Ramipril—coronary artery disease	4.08e-05	0.000435	CcSEcCtD
Bosutinib—Thrombocytopenia—Ramipril—coronary artery disease	4.08e-05	0.000434	CcSEcCtD
Bosutinib—Anaphylactic shock—Timolol—coronary artery disease	4.07e-05	0.000433	CcSEcCtD
Bosutinib—Oedema—Timolol—coronary artery disease	4.07e-05	0.000433	CcSEcCtD
Bosutinib—Pruritus—Pravastatin—coronary artery disease	4.07e-05	0.000433	CcSEcCtD
Bosutinib—Nausea—Clopidogrel—coronary artery disease	4.07e-05	0.000433	CcSEcCtD
Bosutinib—Skin disorder—Ramipril—coronary artery disease	4.05e-05	0.00043	CcSEcCtD
Bosutinib—Infection—Timolol—coronary artery disease	4.05e-05	0.00043	CcSEcCtD
Bosutinib—Vomiting—Simvastatin—coronary artery disease	4.04e-05	0.00043	CcSEcCtD
Bosutinib—Cough—Lisinopril—coronary artery disease	4.04e-05	0.00043	CcSEcCtD
Bosutinib—Nausea—Lovastatin—coronary artery disease	4.04e-05	0.00043	CcSEcCtD
Bosutinib—Rash—Simvastatin—coronary artery disease	4.01e-05	0.000427	CcSEcCtD
Bosutinib—Dermatitis—Simvastatin—coronary artery disease	4.01e-05	0.000426	CcSEcCtD
Bosutinib—Asthenia—Trandolapril—coronary artery disease	4.01e-05	0.000426	CcSEcCtD
Bosutinib—Feeling abnormal—Losartan—coronary artery disease	4e-05	0.000426	CcSEcCtD
Bosutinib—Urticaria—Furosemide—coronary artery disease	4e-05	0.000425	CcSEcCtD
Bosutinib—Diarrhoea—Niacin—coronary artery disease	4e-05	0.000425	CcSEcCtD
Bosutinib—Nervous system disorder—Timolol—coronary artery disease	3.99e-05	0.000425	CcSEcCtD
Bosutinib—Asthenia—Enalapril—coronary artery disease	3.99e-05	0.000424	CcSEcCtD
Bosutinib—Headache—Simvastatin—coronary artery disease	3.98e-05	0.000424	CcSEcCtD
Bosutinib—Abdominal pain—Furosemide—coronary artery disease	3.98e-05	0.000423	CcSEcCtD
Bosutinib—Body temperature increased—Furosemide—coronary artery disease	3.98e-05	0.000423	CcSEcCtD
Bosutinib—Gastrointestinal pain—Losartan—coronary artery disease	3.97e-05	0.000423	CcSEcCtD
Bosutinib—Dizziness—Valsartan—coronary artery disease	3.97e-05	0.000423	CcSEcCtD
Bosutinib—Nausea—Ezetimibe—coronary artery disease	3.96e-05	0.000421	CcSEcCtD
Bosutinib—Skin disorder—Timolol—coronary artery disease	3.96e-05	0.000421	CcSEcCtD
Bosutinib—Dizziness—Olmesartan—coronary artery disease	3.95e-05	0.000421	CcSEcCtD
Bosutinib—Pruritus—Trandolapril—coronary artery disease	3.95e-05	0.00042	CcSEcCtD
Bosutinib—Chest pain—Lisinopril—coronary artery disease	3.94e-05	0.000419	CcSEcCtD
Bosutinib—Arthralgia—Lisinopril—coronary artery disease	3.94e-05	0.000419	CcSEcCtD
Bosutinib—Myalgia—Lisinopril—coronary artery disease	3.94e-05	0.000419	CcSEcCtD
Bosutinib—Asthenia—Telmisartan—coronary artery disease	3.94e-05	0.000419	CcSEcCtD
Bosutinib—Pruritus—Enalapril—coronary artery disease	3.93e-05	0.000419	CcSEcCtD
Bosutinib—Diarrhoea—Pravastatin—coronary artery disease	3.93e-05	0.000419	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	3.91e-05	0.000416	CcSEcCtD
Bosutinib—Discomfort—Lisinopril—coronary artery disease	3.89e-05	0.000414	CcSEcCtD
Bosutinib—Pruritus—Telmisartan—coronary artery disease	3.88e-05	0.000413	CcSEcCtD
Bosutinib—Nausea—Eplerenone—coronary artery disease	3.88e-05	0.000412	CcSEcCtD
Bosutinib—Dizziness—Niacin—coronary artery disease	3.86e-05	0.000411	CcSEcCtD
Bosutinib—Urticaria—Losartan—coronary artery disease	3.86e-05	0.000411	CcSEcCtD
Bosutinib—Body temperature increased—Losartan—coronary artery disease	3.84e-05	0.000409	CcSEcCtD
Bosutinib—Abdominal pain—Losartan—coronary artery disease	3.84e-05	0.000409	CcSEcCtD
Bosutinib—Asthenia—Captopril—coronary artery disease	3.83e-05	0.000407	CcSEcCtD
Bosutinib—Diarrhoea—Trandolapril—coronary artery disease	3.82e-05	0.000406	CcSEcCtD
Bosutinib—Vomiting—Valsartan—coronary artery disease	3.82e-05	0.000406	CcSEcCtD
Bosutinib—Diarrhoea—Enalapril—coronary artery disease	3.81e-05	0.000405	CcSEcCtD
Bosutinib—Dizziness—Pravastatin—coronary artery disease	3.8e-05	0.000405	CcSEcCtD
Bosutinib—Vomiting—Olmesartan—coronary artery disease	3.8e-05	0.000404	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Ramipril—coronary artery disease	3.8e-05	0.000404	CcSEcCtD
Bosutinib—Rash—Valsartan—coronary artery disease	3.79e-05	0.000403	CcSEcCtD
Bosutinib—Dermatitis—Valsartan—coronary artery disease	3.78e-05	0.000403	CcSEcCtD
Bosutinib—Nausea—Simvastatin—coronary artery disease	3.78e-05	0.000402	CcSEcCtD
Bosutinib—Anaphylactic shock—Lisinopril—coronary artery disease	3.78e-05	0.000402	CcSEcCtD
Bosutinib—Oedema—Lisinopril—coronary artery disease	3.78e-05	0.000402	CcSEcCtD
Bosutinib—Pruritus—Captopril—coronary artery disease	3.77e-05	0.000401	CcSEcCtD
Bosutinib—Rash—Olmesartan—coronary artery disease	3.77e-05	0.000401	CcSEcCtD
Bosutinib—Dermatitis—Olmesartan—coronary artery disease	3.77e-05	0.000401	CcSEcCtD
Bosutinib—Headache—Valsartan—coronary artery disease	3.76e-05	0.0004	CcSEcCtD
Bosutinib—Diarrhoea—Telmisartan—coronary artery disease	3.75e-05	0.000399	CcSEcCtD
Bosutinib—Infection—Lisinopril—coronary artery disease	3.75e-05	0.000399	CcSEcCtD
Bosutinib—Headache—Olmesartan—coronary artery disease	3.74e-05	0.000398	CcSEcCtD
Bosutinib—Asthenia—Perindopril—coronary artery disease	3.72e-05	0.000395	CcSEcCtD
Bosutinib—Dyspnoea—Ramipril—coronary artery disease	3.71e-05	0.000395	CcSEcCtD
Bosutinib—Vomiting—Niacin—coronary artery disease	3.71e-05	0.000395	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Timolol—coronary artery disease	3.71e-05	0.000395	CcSEcCtD
Bosutinib—Thrombocytopenia—Lisinopril—coronary artery disease	3.7e-05	0.000393	CcSEcCtD
Bosutinib—Dizziness—Trandolapril—coronary artery disease	3.69e-05	0.000393	CcSEcCtD
Bosutinib—Rash—Niacin—coronary artery disease	3.68e-05	0.000392	CcSEcCtD
Bosutinib—Dermatitis—Niacin—coronary artery disease	3.68e-05	0.000391	CcSEcCtD
Bosutinib—Dizziness—Enalapril—coronary artery disease	3.68e-05	0.000391	CcSEcCtD
Bosutinib—Skin disorder—Lisinopril—coronary artery disease	3.67e-05	0.00039	CcSEcCtD
Bosutinib—Pruritus—Perindopril—coronary artery disease	3.66e-05	0.00039	CcSEcCtD
Bosutinib—Headache—Niacin—coronary artery disease	3.66e-05	0.000389	CcSEcCtD
Bosutinib—Vomiting—Pravastatin—coronary artery disease	3.66e-05	0.000389	CcSEcCtD
Bosutinib—Diarrhoea—Captopril—coronary artery disease	3.65e-05	0.000388	CcSEcCtD
Bosutinib—Dyspnoea—Timolol—coronary artery disease	3.63e-05	0.000386	CcSEcCtD
Bosutinib—Dizziness—Telmisartan—coronary artery disease	3.63e-05	0.000386	CcSEcCtD
Bosutinib—Rash—Pravastatin—coronary artery disease	3.63e-05	0.000386	CcSEcCtD
Bosutinib—Dermatitis—Pravastatin—coronary artery disease	3.62e-05	0.000385	CcSEcCtD
Bosutinib—Decreased appetite—Ramipril—coronary artery disease	3.62e-05	0.000385	CcSEcCtD
Bosutinib—Asthenia—Furosemide—coronary artery disease	3.61e-05	0.000384	CcSEcCtD
Bosutinib—Headache—Pravastatin—coronary artery disease	3.6e-05	0.000383	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Ramipril—coronary artery disease	3.6e-05	0.000383	CcSEcCtD
Bosutinib—Fatigue—Ramipril—coronary artery disease	3.59e-05	0.000382	CcSEcCtD
Bosutinib—Nausea—Valsartan—coronary artery disease	3.57e-05	0.00038	CcSEcCtD
Bosutinib—Pruritus—Furosemide—coronary artery disease	3.56e-05	0.000379	CcSEcCtD
Bosutinib—Nausea—Olmesartan—coronary artery disease	3.55e-05	0.000378	CcSEcCtD
Bosutinib—Vomiting—Trandolapril—coronary artery disease	3.55e-05	0.000378	CcSEcCtD
Bosutinib—Diarrhoea—Perindopril—coronary artery disease	3.54e-05	0.000377	CcSEcCtD
Bosutinib—Decreased appetite—Timolol—coronary artery disease	3.54e-05	0.000377	CcSEcCtD
Bosutinib—Vomiting—Enalapril—coronary artery disease	3.54e-05	0.000376	CcSEcCtD
Bosutinib—Dizziness—Captopril—coronary artery disease	3.53e-05	0.000375	CcSEcCtD
Bosutinib—Rash—Trandolapril—coronary artery disease	3.52e-05	0.000375	CcSEcCtD
Bosutinib—Dermatitis—Trandolapril—coronary artery disease	3.52e-05	0.000374	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Timolol—coronary artery disease	3.52e-05	0.000374	CcSEcCtD
Bosutinib—Fatigue—Timolol—coronary artery disease	3.51e-05	0.000373	CcSEcCtD
Bosutinib—Rash—Enalapril—coronary artery disease	3.51e-05	0.000373	CcSEcCtD
Bosutinib—Dermatitis—Enalapril—coronary artery disease	3.5e-05	0.000373	CcSEcCtD
Bosutinib—Headache—Trandolapril—coronary artery disease	3.5e-05	0.000372	CcSEcCtD
Bosutinib—Vomiting—Telmisartan—coronary artery disease	3.49e-05	0.000371	CcSEcCtD
Bosutinib—Asthenia—Losartan—coronary artery disease	3.49e-05	0.000371	CcSEcCtD
Bosutinib—Headache—Enalapril—coronary artery disease	3.48e-05	0.000371	CcSEcCtD
Bosutinib—Pain—Timolol—coronary artery disease	3.48e-05	0.00037	CcSEcCtD
Bosutinib—Nausea—Niacin—coronary artery disease	3.47e-05	0.000369	CcSEcCtD
Bosutinib—Rash—Telmisartan—coronary artery disease	3.46e-05	0.000368	CcSEcCtD
Bosutinib—Dermatitis—Telmisartan—coronary artery disease	3.46e-05	0.000368	CcSEcCtD
Bosutinib—Diarrhoea—Furosemide—coronary artery disease	3.44e-05	0.000366	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Lisinopril—coronary artery disease	3.44e-05	0.000366	CcSEcCtD
Bosutinib—Pruritus—Losartan—coronary artery disease	3.44e-05	0.000366	CcSEcCtD
Bosutinib—Headache—Telmisartan—coronary artery disease	3.44e-05	0.000366	CcSEcCtD
Bosutinib—Feeling abnormal—Ramipril—coronary artery disease	3.43e-05	0.000365	CcSEcCtD
Bosutinib—Dizziness—Perindopril—coronary artery disease	3.42e-05	0.000364	CcSEcCtD
Bosutinib—Nausea—Pravastatin—coronary artery disease	3.42e-05	0.000363	CcSEcCtD
Bosutinib—Gastrointestinal pain—Ramipril—coronary artery disease	3.41e-05	0.000362	CcSEcCtD
Bosutinib—Vomiting—Captopril—coronary artery disease	3.39e-05	0.000361	CcSEcCtD
Bosutinib—Dyspnoea—Lisinopril—coronary artery disease	3.37e-05	0.000358	CcSEcCtD
Bosutinib—Rash—Captopril—coronary artery disease	3.36e-05	0.000358	CcSEcCtD
Bosutinib—Dermatitis—Captopril—coronary artery disease	3.36e-05	0.000357	CcSEcCtD
Bosutinib—Feeling abnormal—Timolol—coronary artery disease	3.36e-05	0.000357	CcSEcCtD
Bosutinib—Headache—Captopril—coronary artery disease	3.34e-05	0.000355	CcSEcCtD
Bosutinib—Gastrointestinal pain—Timolol—coronary artery disease	3.33e-05	0.000354	CcSEcCtD
Bosutinib—Dizziness—Furosemide—coronary artery disease	3.33e-05	0.000354	CcSEcCtD
Bosutinib—Diarrhoea—Losartan—coronary artery disease	3.32e-05	0.000354	CcSEcCtD
Bosutinib—Nausea—Trandolapril—coronary artery disease	3.32e-05	0.000353	CcSEcCtD
Bosutinib—Urticaria—Ramipril—coronary artery disease	3.31e-05	0.000352	CcSEcCtD
Bosutinib—Nausea—Enalapril—coronary artery disease	3.3e-05	0.000351	CcSEcCtD
Bosutinib—Vomiting—Perindopril—coronary artery disease	3.29e-05	0.00035	CcSEcCtD
Bosutinib—Body temperature increased—Ramipril—coronary artery disease	3.29e-05	0.00035	CcSEcCtD
Bosutinib—Abdominal pain—Ramipril—coronary artery disease	3.29e-05	0.00035	CcSEcCtD
Bosutinib—Decreased appetite—Lisinopril—coronary artery disease	3.28e-05	0.000349	CcSEcCtD
Bosutinib—Rash—Perindopril—coronary artery disease	3.27e-05	0.000347	CcSEcCtD
Bosutinib—Dermatitis—Perindopril—coronary artery disease	3.26e-05	0.000347	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Lisinopril—coronary artery disease	3.26e-05	0.000347	CcSEcCtD
Bosutinib—Nausea—Telmisartan—coronary artery disease	3.26e-05	0.000347	CcSEcCtD
Bosutinib—Fatigue—Lisinopril—coronary artery disease	3.26e-05	0.000346	CcSEcCtD
Bosutinib—Headache—Perindopril—coronary artery disease	3.24e-05	0.000345	CcSEcCtD
Bosutinib—Urticaria—Timolol—coronary artery disease	3.24e-05	0.000344	CcSEcCtD
Bosutinib—Pain—Lisinopril—coronary artery disease	3.23e-05	0.000344	CcSEcCtD
Bosutinib—Body temperature increased—Timolol—coronary artery disease	3.22e-05	0.000342	CcSEcCtD
Bosutinib—Abdominal pain—Timolol—coronary artery disease	3.22e-05	0.000342	CcSEcCtD
Bosutinib—Dizziness—Losartan—coronary artery disease	3.21e-05	0.000342	CcSEcCtD
Bosutinib—Vomiting—Furosemide—coronary artery disease	3.2e-05	0.000341	CcSEcCtD
Bosutinib—Rash—Furosemide—coronary artery disease	3.17e-05	0.000338	CcSEcCtD
Bosutinib—Dermatitis—Furosemide—coronary artery disease	3.17e-05	0.000337	CcSEcCtD
Bosutinib—Nausea—Captopril—coronary artery disease	3.17e-05	0.000337	CcSEcCtD
Bosutinib—Headache—Furosemide—coronary artery disease	3.15e-05	0.000336	CcSEcCtD
Bosutinib—Feeling abnormal—Lisinopril—coronary artery disease	3.11e-05	0.000331	CcSEcCtD
Bosutinib—Gastrointestinal pain—Lisinopril—coronary artery disease	3.09e-05	0.000329	CcSEcCtD
Bosutinib—Vomiting—Losartan—coronary artery disease	3.09e-05	0.000329	CcSEcCtD
Bosutinib—Nausea—Perindopril—coronary artery disease	3.08e-05	0.000327	CcSEcCtD
Bosutinib—Rash—Losartan—coronary artery disease	3.06e-05	0.000326	CcSEcCtD
Bosutinib—Dermatitis—Losartan—coronary artery disease	3.06e-05	0.000326	CcSEcCtD
Bosutinib—Headache—Losartan—coronary artery disease	3.04e-05	0.000324	CcSEcCtD
Bosutinib—Urticaria—Lisinopril—coronary artery disease	3e-05	0.000319	CcSEcCtD
Bosutinib—Nausea—Furosemide—coronary artery disease	2.99e-05	0.000318	CcSEcCtD
Bosutinib—Asthenia—Ramipril—coronary artery disease	2.99e-05	0.000318	CcSEcCtD
Bosutinib—Body temperature increased—Lisinopril—coronary artery disease	2.99e-05	0.000318	CcSEcCtD
Bosutinib—Abdominal pain—Lisinopril—coronary artery disease	2.99e-05	0.000318	CcSEcCtD
Bosutinib—Pruritus—Ramipril—coronary artery disease	2.95e-05	0.000314	CcSEcCtD
Bosutinib—Asthenia—Timolol—coronary artery disease	2.92e-05	0.000311	CcSEcCtD
Bosutinib—Nausea—Losartan—coronary artery disease	2.89e-05	0.000307	CcSEcCtD
Bosutinib—Pruritus—Timolol—coronary artery disease	2.88e-05	0.000306	CcSEcCtD
Bosutinib—Diarrhoea—Ramipril—coronary artery disease	2.85e-05	0.000303	CcSEcCtD
Bosutinib—Diarrhoea—Timolol—coronary artery disease	2.79e-05	0.000296	CcSEcCtD
Bosutinib—Dizziness—Ramipril—coronary artery disease	2.75e-05	0.000293	CcSEcCtD
Bosutinib—CYP3A4—blood—coronary artery disease	2.73e-05	0.000467	CbGeAlD
Bosutinib—Asthenia—Lisinopril—coronary artery disease	2.71e-05	0.000288	CcSEcCtD
Bosutinib—Dizziness—Timolol—coronary artery disease	2.69e-05	0.000286	CcSEcCtD
Bosutinib—Pruritus—Lisinopril—coronary artery disease	2.67e-05	0.000284	CcSEcCtD
Bosutinib—Vomiting—Ramipril—coronary artery disease	2.65e-05	0.000282	CcSEcCtD
Bosutinib—Rash—Ramipril—coronary artery disease	2.63e-05	0.000279	CcSEcCtD
Bosutinib—Dermatitis—Ramipril—coronary artery disease	2.62e-05	0.000279	CcSEcCtD
Bosutinib—Headache—Ramipril—coronary artery disease	2.61e-05	0.000278	CcSEcCtD
Bosutinib—ABCB1—heart—coronary artery disease	2.59e-05	0.000443	CbGeAlD
Bosutinib—Vomiting—Timolol—coronary artery disease	2.59e-05	0.000275	CcSEcCtD
Bosutinib—Diarrhoea—Lisinopril—coronary artery disease	2.58e-05	0.000275	CcSEcCtD
Bosutinib—Rash—Timolol—coronary artery disease	2.57e-05	0.000273	CcSEcCtD
Bosutinib—Dermatitis—Timolol—coronary artery disease	2.57e-05	0.000273	CcSEcCtD
Bosutinib—Headache—Timolol—coronary artery disease	2.55e-05	0.000271	CcSEcCtD
Bosutinib—Dizziness—Lisinopril—coronary artery disease	2.5e-05	0.000266	CcSEcCtD
Bosutinib—Nausea—Ramipril—coronary artery disease	2.47e-05	0.000263	CcSEcCtD
Bosutinib—ABCB1—cardiovascular system—coronary artery disease	2.45e-05	0.000418	CbGeAlD
Bosutinib—Nausea—Timolol—coronary artery disease	2.42e-05	0.000257	CcSEcCtD
Bosutinib—Vomiting—Lisinopril—coronary artery disease	2.4e-05	0.000256	CcSEcCtD
Bosutinib—Rash—Lisinopril—coronary artery disease	2.38e-05	0.000253	CcSEcCtD
Bosutinib—Dermatitis—Lisinopril—coronary artery disease	2.38e-05	0.000253	CcSEcCtD
Bosutinib—Headache—Lisinopril—coronary artery disease	2.37e-05	0.000252	CcSEcCtD
Bosutinib—Nausea—Lisinopril—coronary artery disease	2.24e-05	0.000239	CcSEcCtD
Bosutinib—ABCB1—blood—coronary artery disease	1.93e-05	0.000331	CbGeAlD
Bosutinib—ABCB1—Metabolism—CAT—coronary artery disease	1.66e-07	1.28e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—MAPK1—coronary artery disease	1.66e-07	1.28e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—KIT—coronary artery disease	1.65e-07	1.27e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CXCL8—coronary artery disease	1.65e-07	1.27e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—DCN—coronary artery disease	1.64e-07	1.26e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—PIK3CA—coronary artery disease	1.64e-07	1.26e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—MAPK1—coronary artery disease	1.64e-07	1.26e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CXCL8—coronary artery disease	1.64e-07	1.26e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CASP3—coronary artery disease	1.64e-07	1.26e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—PIK3CA—coronary artery disease	1.63e-07	1.26e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CCND1—coronary artery disease	1.63e-07	1.26e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—IL6—coronary artery disease	1.63e-07	1.25e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—VEGFA—coronary artery disease	1.63e-07	1.25e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—FGF2—coronary artery disease	1.63e-07	1.25e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—PIK3CA—coronary artery disease	1.62e-07	1.25e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—SERPINE1—coronary artery disease	1.62e-07	1.25e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—PIK3CA—coronary artery disease	1.62e-07	1.24e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—APOB—coronary artery disease	1.62e-07	1.24e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—MAPK1—coronary artery disease	1.61e-07	1.24e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—PIK3CA—coronary artery disease	1.61e-07	1.24e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—AKT1—coronary artery disease	1.61e-07	1.24e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—IL6—coronary artery disease	1.61e-07	1.23e-06	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—AKT1—coronary artery disease	1.61e-07	1.23e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NOS3—coronary artery disease	1.6e-07	1.23e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CASP3—coronary artery disease	1.6e-07	1.23e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ALDH2—coronary artery disease	1.6e-07	1.23e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CCND1—coronary artery disease	1.59e-07	1.22e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TGFB1—coronary artery disease	1.59e-07	1.22e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—PIK3CA—coronary artery disease	1.59e-07	1.22e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MMP9—coronary artery disease	1.58e-07	1.22e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—GSK3B—coronary artery disease	1.58e-07	1.22e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CASP3—coronary artery disease	1.58e-07	1.21e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GSTM1—coronary artery disease	1.57e-07	1.21e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CREB1—coronary artery disease	1.57e-07	1.21e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—POMC—coronary artery disease	1.57e-07	1.21e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CASP3—coronary artery disease	1.57e-07	1.21e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—FGF2—coronary artery disease	1.57e-07	1.21e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—JAK2—coronary artery disease	1.56e-07	1.2e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CCND1—coronary artery disease	1.56e-07	1.2e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—IL6—coronary artery disease	1.56e-07	1.2e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—LIPC—coronary artery disease	1.56e-07	1.2e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—HBA1—coronary artery disease	1.56e-07	1.2e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP2C19—coronary artery disease	1.56e-07	1.2e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	1.56e-07	1.2e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—MAPK1—coronary artery disease	1.56e-07	1.2e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—MAPK1—coronary artery disease	1.55e-07	1.19e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—PIK3CA—coronary artery disease	1.55e-07	1.19e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—APOC3—coronary artery disease	1.55e-07	1.19e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—IL6—coronary artery disease	1.55e-07	1.19e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NOS3—coronary artery disease	1.55e-07	1.19e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MMP9—coronary artery disease	1.55e-07	1.19e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—LPL—coronary artery disease	1.54e-07	1.19e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—LDLR—coronary artery disease	1.54e-07	1.18e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—AKT1—coronary artery disease	1.54e-07	1.18e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCL2—coronary artery disease	1.54e-07	1.18e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CCND1—coronary artery disease	1.54e-07	1.18e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL6R—coronary artery disease	1.53e-07	1.18e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—PIK3CA—coronary artery disease	1.53e-07	1.18e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CCND1—coronary artery disease	1.53e-07	1.17e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IL6—coronary artery disease	1.52e-07	1.17e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.52e-07	1.17e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.52e-07	1.17e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—TGFB1—coronary artery disease	1.52e-07	1.17e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MMP9—coronary artery disease	1.51e-07	1.16e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IGF1—coronary artery disease	1.51e-07	1.16e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GPX1—coronary artery disease	1.51e-07	1.16e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—AKT1—coronary artery disease	1.5e-07	1.16e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—JAK2—coronary artery disease	1.5e-07	1.16e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GCLC—coronary artery disease	1.5e-07	1.16e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CETP—coronary artery disease	1.5e-07	1.16e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TGFB1—coronary artery disease	1.49e-07	1.15e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—PIK3CA—coronary artery disease	1.49e-07	1.15e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MMP9—coronary artery disease	1.49e-07	1.15e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—IL6—coronary artery disease	1.49e-07	1.15e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—IL6—coronary artery disease	1.49e-07	1.15e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—MAPK1—coronary artery disease	1.49e-07	1.14e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—SDC1—coronary artery disease	1.49e-07	1.14e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL6—coronary artery disease	1.49e-07	1.14e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—PIK3CA—coronary artery disease	1.48e-07	1.14e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MMP9—coronary artery disease	1.48e-07	1.14e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—AKT1—coronary artery disease	1.48e-07	1.14e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CD36—coronary artery disease	1.47e-07	1.13e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—MAPK1—coronary artery disease	1.47e-07	1.13e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—TGFB1—coronary artery disease	1.46e-07	1.12e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL6—coronary artery disease	1.45e-07	1.12e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.45e-07	1.11e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL6—coronary artery disease	1.45e-07	1.11e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—PIK3CA—coronary artery disease	1.44e-07	1.11e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—AKT1—coronary artery disease	1.44e-07	1.11e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—IL6—coronary artery disease	1.44e-07	1.1e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—SERPINE1—coronary artery disease	1.43e-07	1.1e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—MAPK1—coronary artery disease	1.43e-07	1.1e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL6—coronary artery disease	1.43e-07	1.1e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—AKT1—coronary artery disease	1.43e-07	1.1e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL6—coronary artery disease	1.42e-07	1.1e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—PIK3CA—coronary artery disease	1.42e-07	1.1e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CXCL8—coronary artery disease	1.42e-07	1.09e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—VEGFA—coronary artery disease	1.42e-07	1.09e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—IL6—coronary artery disease	1.41e-07	1.08e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—AKT1—coronary artery disease	1.4e-07	1.08e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.4e-07	1.08e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.4e-07	1.08e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—PIK3CA—coronary artery disease	1.4e-07	1.07e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—MTHFR—coronary artery disease	1.39e-07	1.07e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—VEGFA—coronary artery disease	1.39e-07	1.07e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—FGF2—coronary artery disease	1.39e-07	1.07e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—AKT1—coronary artery disease	1.37e-07	1.06e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—AKT1—coronary artery disease	1.37e-07	1.06e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—MAPK1—coronary artery disease	1.37e-07	1.06e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CXCL8—coronary artery disease	1.37e-07	1.05e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—IL6—coronary artery disease	1.37e-07	1.05e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CTGF—coronary artery disease	1.37e-07	1.05e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—AKT1—coronary artery disease	1.37e-07	1.05e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NOS3—coronary artery disease	1.37e-07	1.05e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CASP3—coronary artery disease	1.36e-07	1.05e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—VEGFA—coronary artery disease	1.36e-07	1.05e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.36e-07	1.05e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GOT2—coronary artery disease	1.36e-07	1.05e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—IL6—coronary artery disease	1.35e-07	1.04e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—PIK3CA—coronary artery disease	1.35e-07	1.04e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—PIK3CA—coronary artery disease	1.35e-07	1.04e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—AKT1—coronary artery disease	1.34e-07	1.03e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—VEGFA—coronary artery disease	1.34e-07	1.03e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—AKT1—coronary artery disease	1.34e-07	1.03e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—VEGFA—coronary artery disease	1.33e-07	1.02e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—JAK2—coronary artery disease	1.33e-07	1.02e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CCND1—coronary artery disease	1.33e-07	1.02e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—AKT1—coronary artery disease	1.33e-07	1.02e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—IL6—coronary artery disease	1.32e-07	1.02e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—AKT1—coronary artery disease	1.32e-07	1.02e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—AGT—coronary artery disease	1.32e-07	1.01e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—IL6—coronary artery disease	1.31e-07	1.01e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—AKT1—coronary artery disease	1.31e-07	1.01e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CASP3—coronary artery disease	1.31e-07	1.01e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TGFB1—coronary artery disease	1.31e-07	1e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—AKT1—coronary artery disease	1.3e-07	9.97e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—APOE—coronary artery disease	1.29e-07	9.94e-07	CbGpPWpGaD
Bosutinib—SRC—Disease—TGFB1—coronary artery disease	1.29e-07	9.94e-07	CbGpPWpGaD
Bosutinib—EGFR—Disease—PIK3CA—coronary artery disease	1.29e-07	9.92e-07	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MMP9—coronary artery disease	1.29e-07	9.9e-07	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MAPK1—coronary artery disease	1.28e-07	9.85e-07	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL6—coronary artery disease	1.28e-07	9.83e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—APOA1—coronary artery disease	1.28e-07	9.83e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CCND1—coronary artery disease	1.28e-07	9.83e-07	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TGFB1—coronary artery disease	1.27e-07	9.8e-07	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—PIK3CA—coronary artery disease	1.27e-07	9.78e-07	CbGpPWpGaD
Bosutinib—SRC—Disease—MAPK1—coronary artery disease	1.27e-07	9.75e-07	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—AKT1—coronary artery disease	1.27e-07	9.73e-07	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL6—coronary artery disease	1.26e-07	9.7e-07	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MAPK1—coronary artery disease	1.25e-07	9.61e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.25e-07	9.61e-07	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—AKT1—coronary artery disease	1.25e-07	9.6e-07	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TGFB1—coronary artery disease	1.25e-07	9.59e-07	CbGpPWpGaD
Bosutinib—LCK—Disease—PIK3CA—coronary artery disease	1.24e-07	9.56e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MMP9—coronary artery disease	1.24e-07	9.54e-07	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL6—coronary artery disease	1.24e-07	9.51e-07	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TGFB1—coronary artery disease	1.23e-07	9.45e-07	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MAPK1—coronary artery disease	1.22e-07	9.41e-07	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TGFB1—coronary artery disease	1.22e-07	9.4e-07	CbGpPWpGaD
Bosutinib—FYN—Disease—AKT1—coronary artery disease	1.22e-07	9.38e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CXCL8—coronary artery disease	1.21e-07	9.34e-07	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—AKT1—coronary artery disease	1.21e-07	9.33e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.21e-07	9.31e-07	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MAPK1—coronary artery disease	1.2e-07	9.26e-07	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MAPK1—coronary artery disease	1.2e-07	9.21e-07	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL6—coronary artery disease	1.2e-07	9.2e-07	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL6—coronary artery disease	1.19e-07	9.17e-07	CbGpPWpGaD
Bosutinib—SRC—Immune System—PIK3CA—coronary artery disease	1.19e-07	9.16e-07	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—AKT1—coronary artery disease	1.18e-07	9.07e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GGT1—coronary artery disease	1.17e-07	9.02e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GOT1—coronary artery disease	1.17e-07	9.02e-07	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—AKT1—coronary artery disease	1.16e-07	8.95e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CASP3—coronary artery disease	1.16e-07	8.94e-07	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—VEGFA—coronary artery disease	1.16e-07	8.89e-07	CbGpPWpGaD
Bosutinib—EGFR—Disease—IL6—coronary artery disease	1.14e-07	8.78e-07	CbGpPWpGaD
Bosutinib—EGFR—Immune System—AKT1—coronary artery disease	1.14e-07	8.77e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCND1—coronary artery disease	1.13e-07	8.7e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PPARG—coronary artery disease	1.13e-07	8.66e-07	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL6—coronary artery disease	1.13e-07	8.66e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—VEGFA—coronary artery disease	1.11e-07	8.57e-07	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—PIK3CA—coronary artery disease	1.11e-07	8.55e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—POMC—coronary artery disease	1.11e-07	8.54e-07	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—AKT1—coronary artery disease	1.1e-07	8.48e-07	CbGpPWpGaD
Bosutinib—LCK—Disease—IL6—coronary artery disease	1.1e-07	8.46e-07	CbGpPWpGaD
Bosutinib—SRC—Disease—PIK3CA—coronary artery disease	1.1e-07	8.46e-07	CbGpPWpGaD
Bosutinib—LCK—Immune System—AKT1—coronary artery disease	1.1e-07	8.46e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MMP9—coronary artery disease	1.1e-07	8.45e-07	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—PIK3CA—coronary artery disease	1.08e-07	8.34e-07	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—PIK3CA—coronary artery disease	1.06e-07	8.16e-07	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TGFB1—coronary artery disease	1.06e-07	8.16e-07	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL6—coronary artery disease	1.06e-07	8.11e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.05e-07	8.1e-07	CbGpPWpGaD
Bosutinib—EGFR—Disease—AKT1—coronary artery disease	1.05e-07	8.1e-07	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—PIK3CA—coronary artery disease	1.05e-07	8.04e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.04e-07	8.03e-07	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MAPK1—coronary artery disease	1.04e-07	8e-07	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—PIK3CA—coronary artery disease	1.04e-07	8e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.04e-07	7.99e-07	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—AKT1—coronary artery disease	1.04e-07	7.99e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CAT—coronary artery disease	1.03e-07	7.88e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TGFB1—coronary artery disease	1.02e-07	7.86e-07	CbGpPWpGaD
Bosutinib—LCK—Disease—AKT1—coronary artery disease	1.02e-07	7.81e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ALB—coronary artery disease	1.01e-07	7.79e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MAPK1—coronary artery disease	1e-07	7.71e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—APOB—coronary artery disease	9.95e-08	7.65e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—VEGFA—coronary artery disease	9.86e-08	7.59e-07	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL6—coronary artery disease	9.84e-08	7.57e-07	CbGpPWpGaD
Bosutinib—SRC—Disease—IL6—coronary artery disease	9.74e-08	7.49e-07	CbGpPWpGaD
Bosutinib—SRC—Immune System—AKT1—coronary artery disease	9.74e-08	7.49e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—NOS3—coronary artery disease	9.69e-08	7.45e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GSTM1—coronary artery disease	9.68e-08	7.45e-07	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL6—coronary artery disease	9.6e-08	7.38e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—LPL—coronary artery disease	9.51e-08	7.31e-07	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL6—coronary artery disease	9.4e-08	7.23e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GPX1—coronary artery disease	9.27e-08	7.13e-07	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL6—coronary artery disease	9.26e-08	7.12e-07	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL6—coronary artery disease	9.21e-08	7.08e-07	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—AKT1—coronary artery disease	9.08e-08	6.98e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TGFB1—coronary artery disease	9.05e-08	6.96e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CD36—coronary artery disease	9.03e-08	6.94e-07	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—PIK3CA—coronary artery disease	9.03e-08	6.94e-07	CbGpPWpGaD
Bosutinib—SRC—Disease—AKT1—coronary artery disease	8.99e-08	6.91e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PPP2CA—coronary artery disease	8.92e-08	6.86e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MAPK1—coronary artery disease	8.88e-08	6.83e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PTGS2—coronary artery disease	8.86e-08	6.81e-07	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—AKT1—coronary artery disease	8.86e-08	6.81e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—PIK3CA—coronary artery disease	8.7e-08	6.69e-07	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—AKT1—coronary artery disease	8.67e-08	6.67e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—MTHFR—coronary artery disease	8.56e-08	6.58e-07	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—AKT1—coronary artery disease	8.54e-08	6.57e-07	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—AKT1—coronary artery disease	8.49e-08	6.53e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—AGT—coronary artery disease	8.13e-08	6.25e-07	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL6—coronary artery disease	8e-08	6.15e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—APOE—coronary artery disease	7.97e-08	6.13e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—APOA1—coronary artery disease	7.88e-08	6.06e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL6—coronary artery disease	7.71e-08	5.93e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—PIK3CA—coronary artery disease	7.7e-08	5.92e-07	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—AKT1—coronary artery disease	7.38e-08	5.67e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—AKT1—coronary artery disease	7.11e-08	5.47e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PPARG—coronary artery disease	6.94e-08	5.34e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—POMC—coronary artery disease	6.84e-08	5.26e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL6—coronary artery disease	6.82e-08	5.25e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—AKT1—coronary artery disease	6.29e-08	4.84e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ALB—coronary artery disease	6.24e-08	4.8e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—NOS3—coronary artery disease	5.97e-08	4.59e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PTGS2—coronary artery disease	5.46e-08	4.2e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PIK3CA—coronary artery disease	5.45e-08	4.19e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—AKT1—coronary artery disease	4.45e-08	3.42e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PIK3CA—coronary artery disease	3.36e-08	2.58e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—AKT1—coronary artery disease	2.74e-08	2.11e-07	CbGpPWpGaD
